SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-19-095261
Filing Date
2019-04-02
Accepted
2019-04-02 09:39:48
Documents
1
Effectiveness Date
2019-04-02

Document Format Files

Seq Description Document Type Size
1 S-8 POS d729685ds8pos.htm S-8 POS 17327
  Complete submission text file 0001193125-19-095261.txt   18543
Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-217831 | Film No.: 19723047
SIC: 2834 Pharmaceutical Preparations